Featured News

CNN reports on the release of GHTC’s policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D, highlighting the need for sustained investments in global health R&D from the United States and greater interagency coordination. GHTC Director Erin Will Morton is quoted.

Learn More
GHTC sends letter urging Senate to oppose provisions in Defense Authorization Act which could threaten medical research

GHTC sent a letter to members of the Senate Armed Services Committee and members of the Senate Appropriations Subcommittee on Defense urging them to oppose provisions in the fiscal year 2017 National Defense Authorization Act that would threaten medical research at the US Department of Defense.

PDF
GHTC/GCSP
Intellectual Property Watch reports on GHTC event, webinar on global health R&D at WHA

Intellectual Property Watch highlights remarks made at a GHTC event and webinar on global health R&D issues on the World Health Assembly (WHA) agenda. 

View
PATH/Satvir Malhotra
Contagion reports on GHTC policy recommendations

Contagion covers the release of GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D, citing recommendations for the report in the areas of financing, coordination, and regulatory policy.

View
PATH/Gabe Bienczycki
Voice of America reports on GHTC policy recommendations

Voice of America explores the recommendations included in GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance health R&D, quoting GHTC Director Erin Will Morton

View
PATH/Rose Slavkovsky
VOA TV2Africa interviews GHTC director on policy report

In a video interview with Voice of America’s TV2Africa, GHTC Director Erin Will Morton discusses GHTC’s report, Achieving a bold vision for global health: Policy solutions to advance global health R&D, noting how years of declining or stagnant US investment in global health R&D could undermine the world’s ability to address global health challenges.

View
View All News
From AIDS to Zika, new report warns stagnant US funding for lifesaving tools against infectious disease threats leaves US and world at serious risk

Even as Congress grapples with the White House on how to fund an emergency response to fight Zika virus, a new report from GHTC warns that overall underfunding for development of lifesaving tools against neglected global diseases is putting the United States and the world at risk, and that emergency funding can’t be allowed to substitute for sustained US investment in research and development (R&D) of global health technologies.

Learn More
GHTC to host 4/19 Congressional briefing to unveil policy report

GHTC will launch its seventh annual policy report at an April 19 briefing on Capitol Hill. Some of the leading voices in global health will discuss policy actions the US government can take to accelerate development of urgently-needed tools to tackle existing and emerging health challenges, meet global health goals, and prepare today for the epidemics of tomorrow.

Learn More
Global Health Council joins GHTC

GHTC is excited to announce that the Global Health Council (GHC) has joined the coalition. GHC is the leading membership organization supporting and connecting advocates, implementers, and stakeholders around global health priorities worldwide.

Learn More
International Vaccine Institute joins GHTC

GHTC is pleased to announce that the International Vaccine Institute (IVI) has joined the coalition. IVI is an independent, nonprofit, international organization headquartered in Seoul, South Korea, that conducts research to discover, develop, and deliver safe, effective, and affordable vaccines for global public health.

Learn More
New report calls for inclusion of global health R&D indicators in SDG framework

As global leaders are set to adopt the Sustainable Development Goals (SDGs) later this month, a new report from GHTC and partners calls for the United Nations and its Member States to strengthen the SDG health targets by including indicators to measure global health R&D progress in the SDG monitoring framework.

Learn More
View All Announcements
National Institute of Allergy and Infectious Diseases
Research Roundup: Update on Zika R&D

In this regular feature on Breakthroughs, we highlight the most promising Zika virus vaccine, drug, and diagnostic candidates as well as vector control approaches. 

Read More
James Gathany
Research Roundup: Viral hepatitis, treatment for persistent Ebola, E. coli–based vaccines

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
Sanofi Pasteur / Patrick Boulen
Yellow fever: Status of research, development, and access to countermeasures against an emerging epidemic

GHTC breaks down the status of R&D for vaccines, drugs, and diagnostics against yellow fever.

Read More
PATH, as secretariat of GHTC
Eight keys to success in building an effective coalition

We share our lessons learned in building a diverse, effective advocacy coalition for global health R&D.

Read More
National Institute of Allergy and Infectious Diseases (NIAID)
Research Roundup: TB drug development, mosquitoes’ secret weapon, and a new platform for antibiotic R&D

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

Read More
View Breakthroughs Blog
GHTC/GCSP
Intellectual Property Watch reports on GHTC event, webinar on global health R&D at WHA

Intellectual Property Watch highlights remarks made at a GHTC event and webinar on global health R&D issues on the World Health Assembly (WHA) agenda. 

View
PATH/Satvir Malhotra
Contagion reports on GHTC policy recommendations

Contagion covers the release of GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance global health R&D, citing recommendations for the report in the areas of financing, coordination, and regulatory policy.

View
PATH/Gabe Bienczycki
Voice of America reports on GHTC policy recommendations

Voice of America explores the recommendations included in GHTC's policy report Achieving a bold vision for global health: Policy solutions to advance health R&D, quoting GHTC Director Erin Will Morton

View
PATH/Rose Slavkovsky
VOA TV2Africa interviews GHTC director on policy report

In a video interview with Voice of America’s TV2Africa, GHTC Director Erin Will Morton discusses GHTC’s report, Achieving a bold vision for global health: Policy solutions to advance global health R&D, noting how years of declining or stagnant US investment in global health R&D could undermine the world’s ability to address global health challenges.

View
CDC/James Gathany
The Hill op-ed highlights funding recommendations from GHTC policy report

In an op-ed in The Hill, Ashley Birkett, director of the PATH Malaria Vaccine Initiative, warns that decreasing US funding for neglected disease R&D could leave the world vulnerable to infectious disease outbreaks, citing findings from GHTC's report Achieving a bold vision for global health: Policy solutions to advance global health R&D.

View
View All GHTC in the Media
GHTC sends letter urging Senate to oppose provisions in Defense Authorization Act which could threaten medical research

GHTC sent a letter to members of the Senate Armed Services Committee and members of the Senate Appropriations Subcommittee on Defense urging them to oppose provisions in the fiscal year 2017 National Defense Authorization Act that would threaten medical research at the US Department of Defense.

PDF
GHTC sends FY17 letters to House and Senate appropriators

GHTC sent letters to the relevant House and Senate appropriations subcommittees asking them to prioritize global health R&D in the fiscal year 2017 (FY17) budget.

Learn More
GHTC sends letter urging Congress to commit to sustainable global health R&D financing, approve emergency Zika request

GHTC sent a letter to all 535 Members of Congress, urging them to commit to a long-term vision for financing global health research that ensures we have the tools necessary to treat both endemic and emerging diseases, like Zika.

PDF
GHTC submits letter to UN High-Level Panel on Access to Medicines

GHTC sent a letter to the UN Secretary General and submitted evidence to the High-Level Panel (HLP) urging them to incorporate the experience of product development partnerships (PDPs), which demonstrate a variety of barriers to access to health technologies.

PDF
GHTC sends letter welcoming new USAID Administrator Gayle Smith

GHTC sent a letter welcoming incoming Administrator of the US Agency for International Development (USAID) Gayle Smith, highlighting the agency’s work on global health R&D and urging her to continue to support this work as administrator. 

PDF

Events

Community Event

USAID
Saving Lives at Birth 6th annual DevelopmentXChange
USAID
Learn More

Community Event

Terrapin
World Anti-Microbial Resistance Congress US 2016
Terrapin
Learn More

Member Event

PATH/Aaron Joel Santos
Vaccinology Course
International Vaccine Institute
Learn More
View All Current & Past Events

Stay Informed

Sign up to receive news and updates from GHTC.
Sign Up Now

Media Inquiries

Marissa Chmiola
Communications Officer
Global Health Technologies Coalition
mchmiola@ghtcoalition.org